Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

著者: Lova Sun, Miles Hsu, Roger B. Cohen, Corey J. Langer, Ronac Mamtani, Charu Aggarwal - JAMA Oncology 2021 被引用: 85

Conflict of Interest Disclosures: Dr Odisho reported personal fees from VSee, LLC outside the submitted work. Dr Hong reported a